{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:32:45Z","timestamp":1783780365566,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.01.048","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T22:15:23Z","timestamp":1486160123000},"page":"1216-1226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"title":["Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation \u2013 A systematic review of randomized trials, observational studies and case reports"],"prefix":"10.1016","volume":"35","author":[{"given":"Evelina","family":"Croce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile F.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika K.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silja","family":"B\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.048_b0005","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2017.01.048_b0010","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/adc.63.10.1268","article-title":"Disseminated BCG in HIV infection","volume":"63","author":"Ninane","year":"1988","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2017.01.048_b0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM197708042970503","article-title":"Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child","volume":"297","author":"Davis","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.01.048_b0020","article-title":"Attenuated measles vaccine in children with acute leukemia","volume":"103","author":"Mitus","year":"1962","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2017.01.048_b0025","unstructured":"Bi\u00e9try F, Pitzurra R, Schwenkglenks M, Meier CR. Helsana-Arzneimittelreport; 2014."},{"key":"10.1016\/j.vaccine.2017.01.048_b0030","first-page":"2517","article-title":"Disseminated primary varicella infection during infliximab treatment","volume":"31","author":"Vonkeman","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2177\/jsci.33.37","article-title":"Onset of modified measles after etanercept treatment in rheumatoid arthritis","volume":"33","author":"Takahashi","year":"2010","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.vaccine.2017.01.048_b0040","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/acr.20045","article-title":"Yellow fever revaccination during infliximab therapy","volume":"62","author":"Scheinberg","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.vaccine.2017.01.048_b0045","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-12-550475","article-title":"How I vaccinate blood and marrow transplant recipients","volume":"127","author":"Carpenter","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2017.01.048_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.01.048_b0055","article-title":"Vaccine response in recipients of HLA mismatched unrelated double unit cord blood transplantation (CBT)","volume":"116","author":"Small","year":"2010","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.vaccine.2017.01.048_b0060","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.vaccine.2015.04.090","article-title":"Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic\/maintenance corticosteroids","volume":"33","author":"Russell","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.048_b0065","unstructured":"Meeting of Global Advisory Committee on Vaccine Safety, 18\u201319 June 2008. Relev \u00c9pid\u00e9miologique Hebd\/Sect D\u2019hygi\u00e8ne Du Secr\u00e9tariat La Soci\u00e9t\u00e9 Des Nations = Wkly Epidemiol Rec\/Heal Sect Secr Leag Nations 2008; 83. p. 287\u201392."},{"key":"10.1016\/j.vaccine.2017.01.048_b0070","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2009.07.082","article-title":"Viscerotropic disease following yellow fever vaccination in Peru","volume":"27","author":"Whittembury","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.048_b0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/annrheumdis-2012-eular.2274","article-title":"Measles, mumps and rubella vaccination safety in patients with juvenile rheumatic diseases taking immunosuppressive drugs","volume":"71","author":"Pileggi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2017.01.048_b0080","first-page":"117","article-title":"Use of a live varicella vaccine to prevent the spread of varicella in handicapped or immunosuppressed children including MCLS (muco-cutaneous lymphnode syndrome) patients in hospitals","volume":"20","author":"Ueda","year":"1977","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2017.01.048_b0085","first-page":"791","article-title":"Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus","volume":"30","author":"Barbosa","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0090","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3497","article-title":"The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study","volume":"13","author":"Zhang","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.vaccine.2017.01.048_b0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1756-185X.2010.01466.x","article-title":"Live polio vaccine exposure while receiving anti-TNF therapy for reactive arthritis","volume":"13","author":"Badsha","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.vaccine.2017.01.048_b0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.vaccine.2017.01.048_b0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2340\/0001555560445447","article-title":"Vaccinia and topical steroids: a case report","volume":"60","author":"Gundersen","year":"1980","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1600-6143.2005.01210.x","article-title":"Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients","volume":"6","author":"Weinberg","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1034\/j.1600-6143.2002.20912.x","article-title":"Varicella infection following varicella vaccination in a liver transplant recipient","volume":"2","author":"Levitsky","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archderm.142.7.943","article-title":"Varicella infection caused by Oka strain vaccine in a heart transplant recipient","volume":"142","author":"Kraft","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0125","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.vaccine.2008.09.076","article-title":"Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation","volume":"26","author":"Shinjoh","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.048_b0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.vaccine.2014.11.052","article-title":"Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation","volume":"33","author":"Shinjoh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.048_b0135","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/bmt.2010.31","article-title":"Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs","volume":"45","author":"Kussmaul","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0140","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bbmt.2011.05.006","article-title":"Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell depleted related and unrelated allogeneic hematopoietic cell transplantation (allHCT)","volume":"17","author":"Chou","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0145","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archneurol.2011.131","article-title":"Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis","volume":"68","author":"Farez","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0150","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2017.01.048_b0155","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/jama.2013.6768","article-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial","volume":"309","author":"Heijstek","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.01.048_b0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/014107689809100305","article-title":"Exacerbation of atopic dermatitis after bacillus Calmette-Gu\u00e9rin vaccination","volume":"91","author":"Dalton","year":"1998","journal-title":"J R Soc Med"},{"key":"10.1016\/j.vaccine.2017.01.048_b0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4137\/DTI.S701","article-title":"Live typhoid vaccine for IBD-patients - well tolerated and with possible therapeutic effect","volume":"3","author":"Nysaeter","year":"2008","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.vaccine.2017.01.048_b0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaad.2011.07.032","article-title":"Live attenuated varicella vaccine: a new effective adjuvant weapon in the battlefield against severe resistant psoriasis, a pilot randomized controlled trial","volume":"66","author":"El-Darouti","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1684\/ejd.2014.2377","article-title":"Study of T helper (17) and T regulatory cells in psoriatic patients receiving live attenuated varicella vaccine therapy in a randomized controlled trial","volume":"24","author":"El-Darouti","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0180","first-page":"3329","article-title":"Beneficial role of bacille calmette-guerin (BCG) vaccination in the management of systemic lupus erythematosus: a report of three cases","volume":"21","author":"Guzman","year":"1983","journal-title":"Philipp J Intern Med"},{"key":"10.1016\/j.vaccine.2017.01.048_b0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3476(05)81545-8","article-title":"Measles vaccination after orthotopic liver transplantation","volume":"123","author":"Rand","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2017.01.048_b0190","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0195","first-page":"427","article-title":"Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation","volume":"9","author":"Pauksen","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2013.10.037","article-title":"Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis","volume":"133","author":"Slifka","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0205","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/acr.22021","article-title":"Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study","volume":"65","author":"Kern\u00e9is","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.vaccine.2017.01.048_b0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15570\/actaapa.2014.15","article-title":"Yellow fever vaccine used in a psoriatic arthritis patient treated with methotrexate: a case report","volume":"23","author":"Stuhec","year":"2014","journal-title":"Acta Dermatovenerologica Alpina, Pannonica, Adriat"},{"key":"10.1016\/j.vaccine.2017.01.048_b0215","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.38960","article-title":"Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever","volume":"67","author":"Oliveira","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.vaccine.2017.01.048_b0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vaccine.2017.01.048_b0225","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jaci.2013.01.045","article-title":"Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease","volume":"131","author":"Tacke","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0230","first-page":"29","article-title":"Application of a live varicella vaccine to hospitalized children and its follow-up study","volume":"25","author":"Katsushima","year":"1982","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2017.01.048_b0235","first-page":"94","article-title":"Varicella vaccination in patients with pediatric rheumatic diseases receiving immunosuppression: proposal of a pre-vaccination checklist to ensure safety","volume":"74","author":"Speth","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0240","first-page":"1521","article-title":"Varicella vaccine in children and adolescents with systemic lupus erythematosus (SLE) Immunogenicity and Safety","volume":"60","author":"Barbosa","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2017.01.048_b0245","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","article-title":"Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids","volume":"62","author":"Pileggi","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.vaccine.2017.01.048_b0250","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/annrheumdis-2012-eular.2800","article-title":"Safety and efficacy of varicella vaccine in patients with juvenile rheumatic diseases: a five years experience","volume":"71","author":"Pileggi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2017.01.048_b0255","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2015.06.086","article-title":"Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy","volume":"33","author":"Toplak","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.048_b0260","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","article-title":"Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy","volume":"50","author":"Lu","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.vaccine.2017.01.048_b0265","doi-asserted-by":"crossref","unstructured":"Farraye F, Wasan S, Berg A, Ganley-Leal L, Liang YM. Immune response and safety of herpes zoster vaccine in IBD patients on methotrexate or thiopurines. In: 77th annu. sci. meet. of am. coll. gastroenterol. Las Vegas, USA, 2012.","DOI":"10.14309\/00000434-201210001-01651"},{"key":"10.1016\/j.vaccine.2017.01.048_b0270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.msard.2013.03.002","article-title":"Varicella vaccination after fingolimod: a case report","volume":"2","author":"Berger","year":"2013","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.vaccine.2017.01.048_b0275","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3899\/jrheum.130170","article-title":"Herpes zoster vaccination in SLE: a pilot study of immunogenicity","volume":"40","author":"Guthridge","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0280","article-title":"An open-label observational pilot study to evaluate the safety and immunogenicity of the herpes zoster vaccina in patients with multiple sclerosis","volume":"80","author":"Mc Graw","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2017.01.048_b0285","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1097\/TP.0b013e31828c6d9e","article-title":"Antiviral immune response after live yellow fever vaccination of a kidney transplant recipient treated with IVIG","volume":"95","author":"Slifka","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2017.01.048_b0290","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00007890-200208270-00020","article-title":"Efficacy and safety of immunization for pre- and post- liver transplant children","volume":"74","author":"Kano","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2017.01.048_b0295","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2015.01.075","article-title":"Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients","volume":"33","author":"Kawano","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.048_b0300","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-3046.2005.00403.x","article-title":"Live virus immunization after orthotopic liver transplantation","volume":"10","author":"Khan","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0305","first-page":"P098","article-title":"Immunization with the measles-mumps-rubella vaccine in children before and after liver transplantation","volume":"47","author":"Gerner","year":"2009","journal-title":"Ger J Gastroenterol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0310","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00865476","article-title":"Attenuated varicella virus vaccine in children with renal transplants","volume":"8","author":"Zamora","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0315","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1399-3046.2005.00279.x","article-title":"Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients","volume":"9","author":"Chaves","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0320","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1182\/blood-2002-01-0212","article-title":"Safety of early immunization against measles\/mumps\/rubella after bone marrow transplantation","volume":"99","author":"Shaw","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2017.01.048_b0325","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bmt.1704878","article-title":"Early measles vaccination in bone marrow transplant recipients","volume":"35","author":"Machado","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0330","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1700909","article-title":"Varicella vaccination in children after bone marrow transplantation","volume":"20","author":"Sauerbrei","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0335","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bbmt.2011.05.006","article-title":"Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)","volume":"17","author":"Chou","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0340","unstructured":"Swissmedic. Product information Stamaril\u00ae. January 2013; 2013."},{"key":"10.1016\/j.vaccine.2017.01.048_b0345","unstructured":"Swissmedic. Product information Priorix\u00ae. Oct 2015; 2015."},{"key":"10.1016\/j.vaccine.2017.01.048_b0350","unstructured":"Swissmedic. Product information Varilrix\u00ae. July 2015; 2015."},{"key":"10.1016\/j.vaccine.2017.01.048_b0355","unstructured":"Swissmedic. Product information ZOSTAVAX\u00ae. Febr 2016; 2016."},{"key":"10.1016\/j.vaccine.2017.01.048_b0360","unstructured":"World Health Organization. Information sheet observed rate of vaccine reactions measles, mumps and rubella vaccines; 2014."},{"key":"10.1016\/j.vaccine.2017.01.048_b0365","series-title":"Vaccines","author":"Plotkin","year":"2012"},{"key":"10.1016\/j.vaccine.2017.01.048_b0370","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","author":"Staples","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.01.048_b0375","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archneurol.2011.1519","article-title":"Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination","volume":"69","author":"Pool","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0380","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-6143.2004.00654.x","article-title":"Adult living donor versus deceased donor liver transplantation: a 6-year single center experience","volume":"5","author":"Maluf","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2017.01.048_b0385","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.transproceed.2005.06.063","article-title":"Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation","volume":"37","author":"Gruttadauria","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.vaccine.2017.01.048_b0390","first-page":"1400","article-title":"Clinical and pathological analysis of acute rejection following orthotopic liver transplantation","volume":"122","author":"Ma","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.vaccine.2017.01.048_b0395","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatol"},{"key":"10.1016\/j.vaccine.2017.01.048_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2014.01.005","article-title":"Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","author":"Askling","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.048_b0405","unstructured":"Centers for Disease Control and Prevention. Notes from the Field: Fatal Yellow Fever Vaccine-Associated Viscerotropic Disease \u2014 Oregon, September 2014. Morb Mortal Wkly Rep 2015: March 20, 2015\/64(10);279\u201381."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T23:52:35Z","timestamp":1749945155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17301135"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation \u2013 A systematic review of randomized trials, observational studies and case reports","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}